The Food and Drug Administration's (FDA) proposed rule would change decades of Laboratory Developed Test (LDT) regulation by expressly considering these in vitro diagnostics (IVDs) medical devices.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Cizzle Biotechnology Holdings PLC - London diagnostics.
EARNINGS: Cizzle Biotechnology loss widens as admin costs mount lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.